Literature DB >> 6692576

Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and non-neuronal enolase, and 14-3-3 protein in circulating human blood cells.

I N Day, R J Thompson.   

Abstract

Five proteins found in the human nervous system have been measured by radioimmunoassay in human red cells, platelets, and lymphocytes. Two neuronal proteins (neurone-specific enolase and 14-3-3 protein) occur in platelets at levels equivalent to their concentration in brain, and in erythrocytes at levels approximately 10% of the level in brain. Two proteins characteristic of astrocytes in the cerebral cortex (creatine kinase BB and aldolase C) occur at low levels in platelets and are virtually undetectable in erythrocytes and lymphocytes. The more widely distributed non-neuronal enolase is present in erythrocytes, platelets and lymphocytes. The neurone-specific enolase and 14-3-3 protein immunoreactivities found in circulating blood cells have been characterised in terms of molecular mass, charge, and dilution characteristics in the respective radioimmunoassay and in each case appears to represent the intact protein. Controlled lysis of erythrocytes releases neurone-specific enolase and 14-3-3 protein in parallel with haemoglobin. The occurrence of brain proteins in circulating blood cells (which appears to be a species-dependent phenomenon) has the practical clinical consequence that minor degrees of especially red cell lysis can produce high serum levels of immunoreactivity. This represents a pitfall in the measurement of these proteins in serum as tumour markers or as indices of damage to the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692576     DOI: 10.1016/0009-8981(84)90295-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Detection of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease Patients Using a New Automated Capillary Western Assay.

Authors:  A Fourier; A Dorey; A Perret-Liaudet; I Quadrio
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

2.  Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury.

Authors:  Ye Tian; Breia Salsbery; Min Wang; Hengjie Yuan; Jing Yang; Zilong Zhao; Xiaoping Wu; Yanjun Zhang; Barbara A Konkle; Perumal Thiagarajan; Min Li; Jianning Zhang; Jing-Fei Dong
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

3.  Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis-detection and evaluation as prognostic biomarkers for clinical outcome.

Authors:  Ivar Tjernberg; Barbro H Skogman; Sigurdur Arnason; Kesia Molewijk; Anna J Henningsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-06-06       Impact factor: 5.103

4.  Multivariate analysis of traumatic brain injury: development of an assessment score.

Authors:  John E Buonora; Angela M Yarnell; Rachel C Lazarus; Michael Mousseau; Lawrence L Latour; Sandro B Rizoli; Andrew J Baker; Shawn G Rhind; Ramon Diaz-Arrastia; Gregory P Mueller
Journal:  Front Neurol       Date:  2015-03-30       Impact factor: 4.003

5.  Autoimmune Profiling Reveals Peroxiredoxin 6 as a Candidate Traumatic Brain Injury Biomarker.

Authors:  John E Buonora; Michael Mousseau; David M Jacobowitz; Rachel C Lazarus; Angela M Yarnell; Cara H Olsen; Harvey B Pollard; Ramon Diaz-Arrastia; Lawrence Latour; Gregory P Mueller
Journal:  J Neurotrauma       Date:  2015-09-11       Impact factor: 5.269

6.  Prediction of Outcome After Endovascular Embolectomy in Anterior Circulation Stroke Using Biomarkers.

Authors:  Fani Pujol-Calderón; Henrik Zetterberg; Erik Portelius; Pia Löwhagen Hendén; Alexandros Rentzos; Jan-Erik Karlsson; Kina Höglund; Kaj Blennow; Lars E Rosengren
Journal:  Transl Stroke Res       Date:  2021-03-15       Impact factor: 6.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.